Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

PaperCitations, authors & open-access status

Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,263 citations, 2018 year and green oa status.

1,263
Citations
2018
Year
green
OA Status

Related on ScholarIQ

Toni K. Choueiri
Author
Jiaheng Qiu
Author
Nature Medicine
Journal
Renal cell carcinoma treatment
Topic
Renal cell carcinoma treatment
Topic
Cancer Immunotherapy and Biomarkers
Topic
470M+ articles · free account